Internal Server Error

Caravel Oculus - About the company

Caravel Oculus is an unfunded company based in Taipei (Taiwan), founded in 2025 by Lyman Lee. It operates as a Developer of pharmaceutical products for the treatment of eye diseases. Caravel Oculus has not raised any funding yet. The company has 2660 active competitors, including 901 funded and 682 that have exited. Its top competitors include companies like Jazz Pharmaceuticals, Sana Biotechnology and Ideaya Biosciences.

Company Details

Developer of pharmaceutical products for the treatment of eye diseases. Research activities focus on identifying existing drug compounds and applying formulation strategies to address clinical needs in ophthalmology. Development efforts target therapeutic options for conditions currently lacking effective medical interventions.
Email ID
*****@caraveloculus.com
Phone Number
+886 **********
Key Metrics
Founded Year
2025
Location
Taipei, Taiwan
Stage
Unfunded
Ranked
Similar Companies
Sign up to download Caravel Oculus' company profile

Caravel Oculus's funding and investors

Caravel Oculus has not raised any funding rounds yet.

Caravel Oculus' founders and board of directors

Founder? Claim Profile
The founders of Caravel Oculus is Lyman Lee. Lyman Lee is the CEO of Caravel Oculus.
Here are the details of Caravel Oculus' key team members:
chrome_extension_cta_illustration
Access Tracxn on any website
Our Google Chrome extension lets you view company details while browsing their websites
Install Tracxn Extension

Caravel Oculus's Competitors and alternates

Top competitors of Caravel Oculus include Jazz Pharmaceuticals, Sana Biotechnology and Ideaya Biosciences. Here is the list of Top 10 competitors of Caravel Oculus, ranked by Tracxn score:
Rank
Company Details
Short Description
Total Funding
Investors
Tracxn Score
1st
Logo for Jazz Pharmaceuticals
Jazz Pharmaceuticals
2003, Dublin (Ireland), Public
Developer of novel biopharmaceutical medicines for unmet medical needs
$265M
82/100
2nd
Logo for Sana Biotechnology
Sana Biotechnology
2018, Seattle (United States), Public
Developer of engineered cell therapies for treating various human diseases
$821M
74/100
3rd
Logo for Ideaya Biosciences
Ideaya Biosciences
2015, San Francisco (United States), Public
Developer of oncology-focused precision medicine using molecular diagnostics
$157M
73/100
4th
Developer of antibody-based therapeutics for cancer therapy
$175M
72/100
5th
Logo for Syndax
Syndax
2005, Waltham (United States), Public
Developer of targeted therapies for the treatment of cancer
$198M
72/100
6th
Logo for Immuneel
Immuneel
2018, Bengaluru (India), Series B
Developer of T-cell therapies for the treatment of cancer
$49.8M
72/100
7th
Logo for C4 Therapeutics
C4 Therapeutics
2016, Cambridge (United States), Public
Developer of small molecule drugs for treating cancer
$223M
71/100
8th
Logo for Erasca
Erasca
2018, San Diego (United States), Public
Developer of small molecule based therapeutics for cancer
$300M
71/100
9th
Logo for Elicio
Elicio
2012, Cambridge (United States), Public
Developer of vaccines for treating cancer
$47.4M
71/100
10th
Logo for Celularity
Celularity
2016, Warren (United States), Public
Developer of allogeneic cell therapies to treat multiple diseases
$290M
71/100
2338th
Logo for Caravel Oculus
Caravel Oculus
2025, Taipei (Taiwan), Unfunded
Developer of pharmaceutical products for the treatment of eye diseases
-
-
22/100
lockGet insights and benchmarks for competitors of 2M+ companies! Sign up today!
Looking for more details on Caravel Oculus's competitors? Click here to see the top ones

Caravel Oculus's Investments and acquisitions

Caravel Oculus has made no investments or acquisitions yet.

Reports related to Caravel Oculus

Here is the latest report on Caravel Oculus's sector:

FAQs about Caravel Oculus

Explore our recently published companies
Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford